Large studies have shown that attempts to correct anemia by erythropoietin did increase the hemoglobin value but did not lead to improved oncological outcomes in HNSCC patients undergoing radiotherapy [37,38]. This evidence concerns the gene EPO and head and neck squamous cell carcinoma.